A few new papers are brewing...

One of them will involve an investigation into young individuals who died suddenly.

I am doing some preliminary research on the individuals who have successfully had VAERS reports filed for them in both the Domestic and Foreign data sets for ‘Sudden death’. This phenomenon is not new in VAERS but it certainly is being observed with higher frequency as of 2021.

Safe to say, sudden death is happening and being reported at rates higher than ever before (big surprise) as per VAERS, and although it is being reported for individuals ages 50+ with more prevalence, it is not limited to a specific age group.

Here is a plot showing the percentages of reports filed according to how long after the injection.

I am particularly interested in the young individuals with no co-morbidities not on medications and without a history of illness or allergies. I have previously written a short piece on this but have updated data. I am focusing on the millennial age group to include individuals 25-44 years of age. Below is a table showing the cases of 25-44 year olds who died suddenly who had no reported co-morbidities, no history, on no medications, with no allergies. There are 23 in total. That may not sound like a lot, but considering the context, it is quite a few.

It is interesting to note that most of the entries were made for males (83%), and 57% have ‘OT’ (which means ‘Other’ method) for VAX_ROUTE which means the product was administered by an unknown route. This is strange to me. About half (43%) died following Dose 1, 43% died associated with Moderna/Spikevax, 57% died associated with Pfizer/Comirnaty and 26% died immediately (NUMDAYS = 0).

It is not yet clear whether the other symptoms in the SYMPTOM fields can be used to narrow in on a definitive cause of death but it seems evidently clear that these deaths were caused by the injections. Just to play my own devil’s advocate, at least, the entries filed immediately were certainly caused by the injections. Many of them reveal cardiac involvement.

More to come…